(Reuters) – The UK health regulator said on Friday it has approved Ronapreve, the antibody developed by Roche and Regeneron, to prevent and treat COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) said the approval was the first in the UK for a monoclonal antibody treatment for the disease caused by the coronavirus.
(Reporting by Muvija M in Bengaluru; Editing by Ramakrishnan M.)
